Illustration: Gabriella Turrisi/Axios
Hims & Hers is planning to acquire Eucalyptus, an Australian digital health company.
Why it matters: The move adds to Hims' growing access to international customers as the company faces threats to its GLP-1 compounding efforts in the U.S.
